Log in

Relevant bibliographies by topics / Alzheimer's disease / Journal articles

To see the other types of publications on this topic, follow the link: Alzheimer's disease.

Journal articles on the topic 'Alzheimer's disease'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Alzheimer's disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Zarrouk, Amira, Meryam Debbabi, Maryem Bezine, et al. "Lipid Biomarkers in Alzheimer's Disease." Current Alzheimer Research 15, no. 4 (2018): 303–12. http://dx.doi.org/10.2174/1567205014666170505101426.

Full text

Abstract:

Background: There are now significant evidences that lipid metabolism is affected in numerous neurodegenerative diseases including Alzheimer’s disease. These dysfunctions lead to abnormal levels of certain lipids in the brain, cerebrospinal fluid and plasma. It is consequently of interest to establish lipid profiles in neurodegenerative diseases. This approach, which can contribute to identify lipid biomarkers of Alzheimers' disease, can also permit to identify new therapeutic targets. It was therefore of interest to focus on central and peripheral biomarkers in Alzheimer's disease. Methods: A

APA, Harvard, Vancouver, ISO, and other styles

2

Graham, Nori. "Alzheimer's Disease International." International Psychogeriatrics 9, no. 1 (1997): 5–6. http://dx.doi.org/10.1017/s1041610297004146.

Full text

Abstract:

Alzheimer's Disease International (ADI) aims to promote and support the work of national Alzheimer associations. Their main purpose is to support carers of people with Alzheimer's disease and related dementias, and to raise awareness of the impact of the disease on the individual and the carer.

APA, Harvard, Vancouver, ISO, and other styles

3

Rajesh, Ravula, Singadi Akhil Reddy, Gandikota Varma Devraj, Raghuram Bhukya, Harika Dasari, and Naaram Srichandana. "Region-based Convolutional Neural Network Driven Alzheimer’s Severity Prediction." International Journal on Recent and Innovation Trends in Computing and Communication 11, no. 6 (2023): 465–70. http://dx.doi.org/10.17762/ijritcc.v11i6.7784.

Full text

Abstract:

It's important to note that Alzheimer's disease can also affect individuals over the age of 60, and in fact, the risk of developing Alzheimer's increases with age. Additionally, while deep learning approaches have shown promising results in detecting Alzheimer's disease, they are not the only techniques available for diagnosis and treatment. That being said, using Region-based Convolutional Neural Network (RCNN) for efficient feature extraction and classification can be a valuable tool in detecting Alzheimer's disease. This new approach to identifying Alzheimer's disease could lead to a more a

APA, Harvard, Vancouver, ISO, and other styles

4

VanDongen, Antonius M. "Arc: A new target for treating alzheimer's disease." Open Access Government 43, no. 1 (2024): 160–61. http://dx.doi.org/10.56367/oag-043-11454.

Full text

Abstract:

Arc: A new target for treating alzheimer's disease Antonius M. VanDongen, Associate Professor from Duke University, walks us through Arc, a new target for treating Alzheimer’s disease. Alois Alzheimer is a German psychiatrist credited with identifying the first case of the debilitating disease named after him. In 1906, he described neurofibrillary tangles and amyloid plaques in his patient’s brain as unique hallmarks of her dementia. Advances in neuroimaging, genetics, and molecular biology have expanded our understanding of the mechanisms underlying Alzheimer’s disease (AD) significantly. But

APA, Harvard, Vancouver, ISO, and other styles

5

Rimmer, Elizabeth. "Alzheimer's Disease International." International Psychiatry 3, no. 4 (2006): 22–23. http://dx.doi.org/10.1192/s1749367600004999.

Full text

Abstract:

Alzheimer's Disease International (ADI) is the international federation of 75 Alzheimer associations throughout the world and is in official relations with the World Health Organization. ADI was established to raise awareness about dementia, strengthen Alzheimer associations and provide a platform for the exchange of knowledge with the ultimate goal of improving the quality of life of people with dementia and their families.

APA, Harvard, Vancouver, ISO, and other styles

6

BAR, Hassan. "Various Infections and Alzheimer's Disease." Virology & Immunology Journal 7, no. 3 (2023): 1–3. http://dx.doi.org/10.23880/vij-16000317.

Full text

Abstract:

Alzheimer's disease (AD) is a major contributor to the worldwide prevalence of dementia. Extracellular-amyloid (A) senile plaques (SP) and intracellular neurofibrillary tangles (NFT) are the neuropathological hallmarks of Alzheimer's disease. Currently, it is believed that both hereditary and environmental variables interact to contribute to the pathophysiology of AD. Despite significant investments in neurological research, the precise molecular basis of AD pathogenesis remains unknown. Multiple studies point to the possibility that pathogenic microorganisms contribute to the development of A

APA, Harvard, Vancouver, ISO, and other styles

7

Zhao, Bin. "Statistical analysis on Alzheimer's disease." Journal of Infectious Diseases & Travel Medicine 7, no. 2 (2023): 1–18. http://dx.doi.org/10.23880/jidtm-16000177.

Full text

Abstract:

Alzheimer's disease is a progressive neurodegenerative disease that occurs mostly in the elderly and has memory impairment as the main clinical symptom. There is no ideal treatment for Alzheimer's disease, so early prevention is important. In this paper, we use brain structural information to diagnose Alzheimer's disease features and cognitive-behavioral characteristics, which is important for early and accurate diagnosis of mild cognitive impairment. To investigate the factors influencing Alzheimer's disease, a correlation analysis model was developed after preprocessing the missing values of

APA, Harvard, Vancouver, ISO, and other styles

8

Conte, G. L., and M. Pomponi. "Alzheimer's or alzheimer-perusini's disease?" European Psychiatry 22 (March 2007): S297. http://dx.doi.org/10.1016/j.eurpsy.2007.01.1008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Corriveau, Roderick A., Walter J. Koroshetz, Jordan T. Gladman, et al. "Alzheimer's Disease–Related Dementias Summit 2016: National research priorities." Neurology 89, no. 23 (2017): 2381–91. http://dx.doi.org/10.1212/wnl.0000000000004717.

Full text

Abstract:

Goal 1 of the National Plan to Address Alzheimer’s Disease is to prevent and effectively treat Alzheimer disease and Alzheimer disease–related dementias by 2025. To help inform the research agenda toward achieving this goal, the NIH hosts periodic summits that set and refine relevant research priorities for the subsequent 5 to 10 years. This proceedings article summarizes the 2016 Alzheimer's Disease–Related Dementias Summit, including discussion of scientific progress, challenges, and opportunities in major areas of dementia research, including mixed-etiology dementias, Lewy body dementia, fr

APA, Harvard, Vancouver, ISO, and other styles

10

Ojetunde, Ayodeji Oluwatobi. "The Neuroprotective and Therapeutic Effects of Medicinal Plants and Natural Products against Aluminium Chloride-Induced Alzheimer’s Disease: Recent Update." Biology, Medicine, & Natural Product Chemistry 13, no. 1 (2024): 7–33. http://dx.doi.org/10.14421/biomedich.2024.131.7-33.

Full text

Abstract:

Alzheimer's disease currently affects more than 35 million individuals worldwide. Aluminium has been implicated in the pathogenesis of various cognitive disorders. Meanwhile, aluminium chloride (AlCl3) has a significant impact on the progression of neurodegenerative diseases including Alzheimer's disease. The majority of Alzheimer's disease medications now on the market are cholinesterase inhibitors. However, the effectiveness of these drugs is limited because they can't totally arrest the progression of the disease. The utilization of medicinal plants and natural products may present excellen

APA, Harvard, Vancouver, ISO, and other styles

11

Sree, M. Monika Bhargavi Sandhya. "Early detection of Alzheimer’s Disease using Deep Learning." INTERANTIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT 08, no. 05 (2024): 1–5. http://dx.doi.org/10.55041/ijsrem34463.

Full text

Abstract:

alzheimer's Disease (AD) is a progressive neurodegenerative disorder that affects millions of people worldwide and causes cognitive impairment. It is the most common cause of dementia, a general term for a decline in cognitive abilities that interfere with daily life. Deep Learning, the subset of Artificial Intelligence is used in the early detection of Alzheimer's Disease. The human-level performance of the Deep Learning algorithm has been effectively shown in different disciplines. There isn’t a specific algorithm that is universal, but various Deep Learning algorithms, are used for the earl

APA, Harvard, Vancouver, ISO, and other styles

12

Heckmann, Bradlee. "Beyond amyloid: What's next for Alzheimers disease therapeutics?" Open Access Government 38, no. 1 (2023): 116–17. http://dx.doi.org/10.56367/oag-038-10770.

Full text

Abstract:

Beyond amyloid: What's next for Alzheimers disease therapeutics? Bradlee Heckmann, PhD, from USF Health Neuroscience Institute, Byrd Alzheimer's Center & Asha Therapeutics, in this discussion goes beyond amyloid, asking what's next for Alzheimer's Disease therapeutics. The recent approvals of aducanumab and lecanamab, targeting amyloid beta, a key pathogenic hallmark of Alzheimer's Disease (AD), represent an impressive step forward in developing new treatment options for one of the most devastating neurological diseases. AD impacts over 5 million individuals in the United States and an est

APA, Harvard, Vancouver, ISO, and other styles

13

Ali, Shakir, Kashif Saghar, Syed Zaffar Iqbal, Syed Ainullah Agha, Azeem Ullah, and Muhammad Essa Siddique. "Enhancing Alzheimer's Disease Diagnosis through Magnetic Resonance Imaging: An Analysis using VGG19 Architectures." Asian Bulletin of Big Data Management 4, no. 4 (2024): 461–80. https://doi.org/10.62019/abbdm.v4i4.284.

Full text

Abstract:

Early detection of Alzheimer's disease (AD) is an area of much research since early diagnosis can offer patient better treatment and enhanced care. In this work we propose a deep learning approach to detect Alzheimer’s disease using the VGG-19 architecture, one of the state-of-the-art convolutional neural networks (CNN). In this work we utilized a dataset composed of a heterogeneous set of brain MRI images from healthy subjects and Alzheimer patients, they are part of the ADNI (Alzheimer's Disease Neuroimaging Initiative). The dataset was preprocessed with a few techniques such as image normal

APA, Harvard, Vancouver, ISO, and other styles

14

Samborska, Julia, Paweł Więckowiak, Karina Stelmaszak, et al. "The impact of the ketogenic diet on the health of patients with Alzheimer’s disease." Journal of Education, Health and Sport 52 (January 11, 2024): 98–110. http://dx.doi.org/10.12775/jehs.2024.52.007.

Full text

Abstract:

INTRODUCTION: Diet is an integral element of every individual's health. Its impact on the functioning of the human body has fascinated scientists for years. One of the diets that alters the mechanism of the body's functioning is the ketogenic diet. The impact of the ketogenic diet on various disorders is still under investigation. It is known to have shown numerous benefits in reducing epileptic seizures, but its impact on other neurological disorders is less known. In this literature review, the efficacy of ketogenic therapies was assessed in Alzheimer's disease.  AIM OF STU

APA, Harvard, Vancouver, ISO, and other styles

15

Tulbă, Delia, Liviu Cozma, Bogdan Ovidiu Popescu, and Eugenia Irene Davidescu. "Dysautonomia in Alzheimer's Disease." Medicina 56, no. 7 (2020): 337. http://dx.doi.org/10.3390/medicina56070337.

Full text

Abstract:

Alzheimer's disease is the most common neurodegenerative disorder, and its prevalence increases with age. Although there is a large amount of scientific literature focusing on Alzheimer's disease cardinal cognitive features, autonomic nervous system dysfunction remains understudied despite being common in the elderly. In this article, we reviewed the evidence for autonomic nervous system involvement in Alzheimer's disease. We identified four major potential causes for dysautonomia in Alzheimer's disease, out of which two are well-studied (comorbidities and medication) and two are rather hypoth

APA, Harvard, Vancouver, ISO, and other styles

16

Harshitha, Gowthami Chamarajan, and Charishma Y. "Alzheimer's Disease: A Survey." International Journal of Artificial Intelligence 8, no. 1 (2021): 33–39. http://dx.doi.org/10.36079/lamintang.ijai-0801.220.

Full text

Abstract:

Alzheimer's Diseases (AD) is one of the type of dementia. This is one of the harmful disease which can lead to death and yet there is no treatment. There is no current technique which is 100% accurate for the treatment of this disease. In recent years, Neuroimaging combined with machine learning techniques have been used for detection of Alzheimer's disease. Based on our survey we came across many methods like Convolution Neural Network (CNN) where in each brain area is been split into small three dimensional patches which acts as input samples for CNN. The other method used was Deep Neural Ne

APA, Harvard, Vancouver, ISO, and other styles

17

Förstl, Hans, Alistair Burns, Phil Luthert, Nigel Cairns, and Raymond Levy. "The Lewy-Body Variant of Alzheimer's Disease." British Journal of Psychiatry 162, no. 3 (1993): 385–92. http://dx.doi.org/10.1192/bjp.162.3.385.

Full text

Abstract:

At post-mortem, Lewy bodies (LBs) were found in the brainstem and neocortex of eight out of 65 patients who had been collected during a prospective long-term study on clinically diagnosed Alzheimer’s disease. All eight patients had accompanying Alzheimer pathology which was less severe than in a sample of eight age and sex-matched patients from the same study with neuropathologically verified Alzheimer's disease. Parkinsonian features were more common in patients with LBs. There were no particular differences in duration of illness, severity of cognitive impairment, presence of hallucinations,

APA, Harvard, Vancouver, ISO, and other styles

18

Sianturi, Aditya Gloria Monalisa. "Stadium, Diagnosis, dan Tatalaksana Penyakit Alzheimer." Majalah Kesehatan Indonesia 2, no. 2 (2021): 39–44. http://dx.doi.org/10.47679/makein.202132.

Full text

Abstract:

Dementia is a general term for loss of memory that can occur along with behavioral or psychological symptoms in patients. The first cause of dementia patients is Alzheimer's disease. Alzheimer’s disease is a brain degenerative disease and the most common cause of dementia. In Alzheimer’s disease, there are three development stages, which is stage 1, stage 2, and stage 3 with different clinical symptoms at each stage. There are several clinical criteria for establishing a definitive diagnosis of Alzheimer’s disease and also support examinations have to be carried out. Until now, Alzheimer’s tre

APA, Harvard, Vancouver, ISO, and other styles

19

Monisha, M., K. M. Harshitha, N. H. Dhanalakshmi, Kokatam Sai Prakash Reddy, C. R. Nagarathna, and M. Kusuma. "Early detection of Alzheimer’s: Modalities and Methods." March 2022 4, no. 1 (2022): 69–79. http://dx.doi.org/10.36548/jaicn.2022.1.005.

Full text

Abstract:

Alzheimer’s disease belongs to the group of neurodegenerative diseases and is considered as one of the most destructive and severe diseases of the human nervous system. There is presently no quick and cost-effective method for routinely screening individuals of age 65 and older for Alzheimer's disease, the most prevalent type of neurodegenerative dementia. Over 5.2 million Americans already suffer from this condition, with the number anticipated to rise to 7.7 million by 2030. This paper discusses how the use of Machine learning concepts has upgraded the detection of Alzheimer's disease in the

APA, Harvard, Vancouver, ISO, and other styles

20

Koberskaya, N. N. "Alzheimer's disease." Neurology, Neuropsychiatry, Psychosomatics 11, no. 3S (2019): 52–60. http://dx.doi.org/10.14412/2074-2711-2019-3s-52-60.

Full text

Abstract:

Despite progress made in laboratory methods, genetic studies, and modern neuroimaging, the diagnosis of diseases that cause dementia makes difficulties. The review presents an update on the epidemiology, risk factors, pathogenesis, clinical presentation, diagnosis, and treatment of Alzheimer's disease (AD). It discusses the issues of symptomatic and pathogenetic treatments and combination therapy for AD. The efficacy of memantine (akatinol memantine) and the expediency of its use at different stages of the disease in patients with AD are noted. Non-pharmacological treatments for this disease,

APA, Harvard, Vancouver, ISO, and other styles

21

Alina Atif. "Study of Treatment Pattern of Neurodegenerative Diseases in a Pakistani Context." JMMC 12, no. 2 (2022): 165–74. http://dx.doi.org/10.62118/jmmc.v12i2.236.

Full text

Abstract:

Introduction: Neurodegenerative disease is a multi-factorial disease which isattributed to the constant degeneration of the function and structure of central andperipheral nervous system. Alzheimer and Parkinson’s diseases are common degenerative diseases all over the world including Pakistan.Objectives: To find out the disease treatment pattern of neurodegenerative diseases (Alzheimer's disease and Parkinson’s disease) in a Pakistani context. The studywill help the practicing neuro physicians in Pakistan to get an insight about the findings.Methodology: This study was conducted at private hos

APA, Harvard, Vancouver, ISO, and other styles

22

Madhuri, Badole, Rane Siddhesh, Bharne Atharv, and Karpe Mayur. "Personalized Alzheimer's Disease Progression Prediction with Machine Learning." Personalized Alzheimer's Disease Progression Prediction with Machine Learning 9, no. 1 (2024): 6. https://doi.org/10.5281/zenodo.10567352.

Full text

Abstract:

One of the most prevalent diseases in the world is Alzheimer’s (AD). It is a neurological condition that can lead to cognitive decline and memory loss. Both the senior population and the prevalence of diseases affecting them have dramatically increased in recent years. It is critical to categorize the progression of Alzheimer’s disease. Alzheimer's disease (AD) is a complicated neurological ailment that progresses in different ways for each individual. In this study, we present a novel approach to personalised Alzheimer's disease progression prediction using machine learning techni

APA, Harvard, Vancouver, ISO, and other styles

23

Barde, Ms Sonal R. "A Short Review on Nutritional Management of Alzheimer Disease." International Journal for Research in Applied Science and Engineering Technology 12, no. 7 (2024): 1586–600. http://dx.doi.org/10.22214/ijraset.2024.63797.

Full text

Abstract:

Abstract: Amyloid-(A) protein is densely deposited in the brain in Alzheimer's disease (AD), a neurodegenerative condition that also causes memory loss and dementia. There is neuronal destruction and deterioration of neural connections in the cerebral cortex region of the brain in Alzheimer's disease, as well as significant loss of brain mass. It is critical to review medication history, family history, and symptoms when diagnosing Alzheimer's dementia. Alzheimer's disease symptoms usually appear after the age of 65, but the types of Alzheimer disease that run-in families occur earlier. When A

APA, Harvard, Vancouver, ISO, and other styles

24

Cummings, Jeffrey L. "Update on Alzheimer's Disease: One Hundred Years After Dr. Alois Alzheimer." CNS Spectrums 13, S2 (2008): 4–6. http://dx.doi.org/10.1017/s1092852900002819.

Full text

Abstract:

Alzheimer's disease was first described by Alois Alzheimer in 1906, and first appeared in the medical literature in 1907. The medical community has been ruminating about Alzheimer's disease for over 100 years, and only recently have Alzheimer's disease therapies begun to emerge. However, many vital questions remain, pertinent not only to physicians but to the public at large. For example, how likely is it that a particular individual will develop Alzheimer's disease? What can one do to avoid getting Alzheimer's disease? What are the current and promising treatments for Alzheimer's disease? Whi

APA, Harvard, Vancouver, ISO, and other styles

25

Hemangkorn, Nicha, Pamonphon Phummai, and Patranan Punyacharoen. "Effects of Essential Oils and Aromatic Plants on Alzheimer’s Disease and Dementia." International Journal of Science and Healthcare Research 6, no. 3 (2021): 350–58. http://dx.doi.org/10.52403/ijshr.20210760.

Full text

Abstract:

The primary objective of this research was to investigate how beneficial essential oils and aromatic plants are at curing Alzheimer’s disease and dementia. Alzheimer’s Disease (AD) is known to be one of the most incurable prevalent diseases in the elderly. Agitation, cognitive impairments, communication difficulty, irritability, and confusion may advance in AD patients. Even though the behavioral causes contributing to the disease have not yet been discovered, aggregation of tau and amyloid proteins is found in the brain of patients with Alzheimer’s. With numerous experiments conducted on thes

APA, Harvard, Vancouver, ISO, and other styles

26

Appel, Jason, Elizabeth Potter, Qian Shen, et al. "A Comparative Analysis of Structural Brain MRI in the Diagnosis of Alzheimer’s Disease." Behavioural Neurology 21, no. 1-2 (2009): 13–19. http://dx.doi.org/10.1155/2009/103123.

Full text

Abstract:

Dementia is a debilitating and life-altering disease which leads to both memory impairment and decline of normal executive functioning. While causes of dementia are numerous and varied, the leading cause among patients 60 years and older is Alzheimer’s disease. The gold standard for Alzheimer’s diagnosis remains histological identification of amyloid plaques and neurofibrillary tangles within the medial temporal lobe, more specifically the entorhinal cortex and hippocampus. Although no definitive cure for Alzheimer's disease currently exists, there are treatments targeted at preserving cogniti

APA, Harvard, Vancouver, ISO, and other styles

27

Shahzadi, Maria, Bareera Saeed, Muhammad Azzam Khan, et al. "A Review on the Techniques for Early Diagnosis of Alzheimer’s Disease." Lahore Garrison University Journal of Life Sciences 6, no. 03 (2022): 268–81. http://dx.doi.org/10.54692/lgujls.2022.0603228.

Full text

Abstract:

Alzheimer’s disease is a neurological condition in which there is rapid deterioration of the brain and it affects around 50 million people globally. The most obvious sign of Alzheimer’s is dementia which is primarily an affliction of old age. Majority of the people presenting with dementia in old age are Alzheimer’s patients. The symptoms of Alzheimer’s disease are debilitating and have the ability to utterly disrupt a person's normal life. It is only discovered after this terrible disease has destroyed all neurons, thus there is little chance to cure it or reverse the adverse effects. There a

APA, Harvard, Vancouver, ISO, and other styles

28

Hoxha, Donika, Biljana Bauer, Gjoshe Stefkov, and Gresa Hoxha. "Phenolic phytochemicals for treatment of Alzheimer’s condition - a review." 68 68, no. 02 (2022): 3–15. http://dx.doi.org/10.33320/maced.pharm.bull.2022.68.02.001.

Full text

Abstract:

The progressive neurodegenerative disease, Alzheimer's disease, affects daily life due to severe memory loss and declining cognitive function. Alzheimer's disease has several hypotheses for its pathophysiology, and on the basis of those hypotheses, researchers are exploring a variety of pathologic targets to find a cure or symptomatic treatment. It has long been known that plants are effective in treating dementia, amnesia, and Alzheimer's disease. A lot of preclinical and clinical studies on plant-based drugs have shown promising results in treating the disease. In this review, we will focus

APA, Harvard, Vancouver, ISO, and other styles

29

Shua-Haim, Joshua R., and Joel S. Gross. "Alzheimer's Syndrome, Not Alzheimer's Disease." Journal of the American Geriatrics Society 44, no. 1 (1996): 96–97. http://dx.doi.org/10.1111/j.1532-5415.1996.tb05648.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Hyman, Bradley T. "Alzheimer's disease or Alzheimer's diseases? clues from molecular epidemiology." Annals of Neurology 40, no. 2 (1996): 135–36. http://dx.doi.org/10.1002/ana.410400202.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Natarajan, M., and S. Sathiamoorthy. "Identification of Alzheimer Disease: A Literature Survey." Asian Journal of Electrical Sciences 7, no. 2 (2018): 46–50. http://dx.doi.org/10.51983/ajes-2018.7.2.2162.

Full text

Abstract:

Medical imaging works an essential part in the area of medical science. In today scenario, image segmentation is utilized to extricate abnormal tissues from normal tissues directly in medical images. Noise in an image is unacceptable to us as it interrupts and deteriorates the condition of the image. Noise removal is perpetually a challenging responsibility so as of edge protection when the strength of the disturbing noise in the initial image is enormous. Alzheimer's disease is a neurological dysfunction in which the brain death causes cognitive decline and Memory Loss. A neurodegenerative ki

APA, Harvard, Vancouver, ISO, and other styles

32

Gemiralda, Rika Mutiara, Marlaokta Marlaokta, and Marlaokta Marlaokta. "Efek Neuroprotektor Kunyit pada Pasien Alzheimer." Jurnal Ilmu Keperawatan Jiwa 2, no. 3 (2019): 171. http://dx.doi.org/10.32584/jikj.v2i3.431.

Full text

Abstract:

Alzheimer merupakan penyakit neurogeneratif kronis progresif. Penyakit ini ditandai dengan gangguan fungsi luhur seperti bahasa, kalkulasi, kapasitas belajar dan sulit mengambil keputusan. ‘Pikun’ merupakan istilah yang digunakan masyarakat untuk menggambarkan penyakit ini. Kehilangan memori jangka pendek merupakan kekhasan dari penyakit ini yang menyebabkan penurunkan produktivitas. Alzheimer sering terjadi pada usia > 65 tahun dan juga ditemukan pada sekitar usia 40 tahun. Kunyit (Curcuma longa L.) merupakan tanaman yang berfungsi sebagai neuroprotektor karena dapat menghambat Protein Tau

APA, Harvard, Vancouver, ISO, and other styles

33

Adji, Ragil Parameswari. "Eksplorasi Efektivitas Asam Galat Sebagai Neuroprotektif dalam Menghambat Penyakit Alzheimer : Literatur Review." Jurnal Cakrawala Akademika 1, no. 6 (2025): 2174–88. https://doi.org/10.70182/jca.v1i6.352.

Full text

Abstract:

Alzheimer s disease is one of the diseases that continues to increase where there have been about 50 million cases in the world. Alzheimer's disease is a neurodegenerative disorder characterized by progressive cognitive decline and memory loss that often occurs in the elderly. Gallic acid is a type of phytochemical compound that is high in antioxidants and is considered to slow the progression of Alzheimer's disease because it can avoid or neutralize the damaging effects of free radicals. However, there are still few scientific articles that explain the effect of gallic acid on Alzheimer's dis

APA, Harvard, Vancouver, ISO, and other styles

34

Kesken, Serdar. "Alzheimer's Disease." Journal of Tepecik Education and Research Hospital 5, no. 1 (1995): 11–20. http://dx.doi.org/10.5222/terh.1995.23722.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Kicherova, O. A., and L. I. Reikhert. "Alzheimer's disease." Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118, no. 1 (2018): 77. http://dx.doi.org/10.17116/jnevro20181181177-81.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Buckwalter, Kathleen Coen, Ivo L. Abraham, and Marcia M. Neundorfer. "Alzheimer's Disease." Nursing Clinics of North America 23, no. 1 (1988): 1–9. http://dx.doi.org/10.1016/s0029-6465(22)01361-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Billig, Nathan. "Alzheimer's Disease." Nursing Clinics of North America 23, no. 1 (1988): 125–33. http://dx.doi.org/10.1016/s0029-6465(22)01369-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Scheltens, Philip, Bart De Strooper, Miia Kivipelto, et al. "Alzheimer's disease." Lancet 397, no. 10284 (2021): 1577–90. http://dx.doi.org/10.1016/s0140-6736(20)32205-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Hanyu, Haruo. "Alzheimer's disease." Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 50, no. 5 (2013): 622–24. http://dx.doi.org/10.3143/geriatrics.50.622.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Cummings, Jeffrey L. "Alzheimer's Disease." New England Journal of Medicine 351, no. 1 (2004): 56–67. http://dx.doi.org/10.1056/nejmra040223.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

James, D. Geraint. "Alzheimer's disease." Journal of Medical Biography 18, no. 3 (2010): 132. http://dx.doi.org/10.1258/jmb.2009.009082.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Querfurth, Henry W., and Frank M. LaFerla. "Alzheimer's Disease." New England Journal of Medicine 362, no. 4 (2010): 329–44. http://dx.doi.org/10.1056/nejmra0909142.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Gorelick, Philip B., and Fernando G. Bózzola. "Alzheimer's disease." Postgraduate Medicine 89, no. 4 (1991): 231–40. http://dx.doi.org/10.1080/00325481.1991.11700876.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Skelton, William Paul, and Nadine Khouzam Skelton. "Alzheimer's disease." Postgraduate Medicine 90, no. 4 (1991): 33–41. http://dx.doi.org/10.1080/00325481.1991.11701056.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Walsh, Arthur C. "Alzheimer's Disease." Canadian Journal of Psychiatry 30, no. 3 (1985): 236. http://dx.doi.org/10.1177/070674378503000324.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Leite, Cinthya, Terce Liana Mota de Menezes, Èrica Verônica de Vasconcelos Lyra, and Cláudia Marina Tavares de Araújo. "Alzheimer's disease." Arquivos de Neuro-Psiquiatria 71, no. 3 (2013): 201. http://dx.doi.org/10.1590/s0004-282x2013000300018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

NAKAMURA, Shigenobu. "Alzheimer's disease." Japanese Journal of Medicine 28, no. 6 (1989): 793–95. http://dx.doi.org/10.2169/internalmedicine1962.28.793.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Selkoe, D. J. "Alzheimer's Disease." Cold Spring Harbor Perspectives in Biology 3, no. 7 (2011): a004457. http://dx.doi.org/10.1101/cshperspect.a004457.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Hunter, R. Stephen. "Alzheimer's Disease." Science & Technology Libraries 6, no. 1-2 (1985): 155–67. http://dx.doi.org/10.1300/j122v06n01_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Gillen, Carol. "Alzheimer's Disease." Science & Technology Libraries 13, no. 2 (1993): 37–55. http://dx.doi.org/10.1300/j122v13n02_03.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!